Nov 6 (Reuters) - Teva Pharmaceutical Industries Ltd
:
* TEVA ANNOUNCES STRONG FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2024, LED BY GENERICS PERFORMANCE AND INNOVATIVE PORTFOLIO GROWTH; RAISES 2024 FINANCIAL OUTLOOK INCLUDING ON REVENUES, ADJUSTED EBITDA AND NON-GAAP EPS
* TEVA OUTLOOK FY24 REVENUE $16.1 BILLION - $16.5 BILLION
* TEVA OUTLOOK FY24 EPS $2.40 - $2.50
* FY2024 EARNINGS PER SHARE VIEW $2.44, REVENUE VIEW $16.26 BILLION -- LSEG IBES DATA
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.